Stallergènes SA

Présentation : Stallergenes is a biopharmaceutical laboratory specializing in the research, development, manufacturing and marketing of products extracted from allergens and used for desensitization treatment of allergy-related respiratory ailments (primarily rhino-conjunctivitis and allergic asthma).
The group's activity is organized essentially around two families of products:
- desensitization treatments: prescribed in injectable or sublingual form;
- in vitro and in vivo diagnostic products: for measuring the patient's sensitivity to certain allergens.
At the end of 2010, Stallergenes had one production site in France.
Net sales are distributed geographically as follows: Southern Europe (71.7%), Europe (24.2%) and other (4.1%).